IP Verse

Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions - EP2791160

The patent EP2791160 was granted to Moderna on Mar 2, 2022. The application was originally filed on Dec 14, 2012 under application number EP12858350A. The patent is currently recorded with a legal status of "Revoked".

EP2791160

MODERNA
Application Number
EP12858350A
Filing Date
Dec 14, 2012
Status
Revoked
Apr 18, 2025
Grant Date
Mar 2, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECHDec 2, 2022WILKADMISSIBLE
ETHERNA IMMUNOTHERAPIESDec 2, 2022REEKMANSADMISSIBLE
MAIWALDDec 2, 2022MAIWALDADMISSIBLE
PFIZERDec 2, 2022EDERADMISSIBLE
WITHERS & ROGERSDec 2, 2022GRAF VON STOSCHADMISSIBLE
KILBURN & STRODEDec 2, 2022KILBURN & STRODEWITHDRAWN
SEQIRUS UKDec 1, 2022CARPMAELS & RANSFORDADMISSIBLE
SANOFISep 26, 2022CARPMAELS & RANSFORDADMISSIBLE
PATENT BOUTIQUEJun 24, 2022PATENT BOUTIQUEADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 18, 2022WICHMANNADMISSIBLE

Patent Citations (74) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2009286852
EXAMINATIONUS2009088721
EXAMINATIONWO2009046739
EXAMINATIONWO2010144740
INTERNATIONAL-SEARCH-REPORTUS2002064517
INTERNATIONAL-SEARCH-REPORTUS2002130430
INTERNATIONAL-SEARCH-REPORTUS2006018971
INTERNATIONAL-SEARCH-REPORTUS2008274463
INTERNATIONAL-SEARCH-REPORTUS2009264511
INTERNATIONAL-SEARCH-REPORTUS2010015232
INTERNATIONAL-SEARCH-REPORTUS2011244026
INTERNATIONAL-SEARCH-REPORTUS6303378
INTERNATIONAL-SEARCH-REPORTWO2011130624
OPPOSITIONEP2578685
OPPOSITIONEP2691101
OPPOSITIONEP2833920
OPPOSITIONEP2849799
OPPOSITIONEP3611266
OPPOSITIONUS2005143336
OPPOSITIONUS2009286852
OPPOSITIONUS2011223257
OPPOSITIONUS2012058519
OPPOSITIONUS533537
OPPOSITIONUS533554
OPPOSITIONUS576705
OPPOSITIONUS618862
OPPOSITIONUS618873
OPPOSITIONUS618885
OPPOSITIONUS618896
OPPOSITIONUS618953
OPPOSITIONUS618957
OPPOSITIONUS648244
OPPOSITIONUS681712
OPPOSITIONUS696381
OPPOSITIONUS709303
OPPOSITIONUS712490
OPPOSITIONUS7479573
OPPOSITIONUS8058069
OPPOSITIONWO2007024708
OPPOSITIONWO2008083949
OPPOSITIONWO2008103276
OPPOSITIONWO2009051451
OPPOSITIONWO2010129687
OPPOSITIONWO2011005799
OPPOSITIONWO2011068810
OPPOSITIONWO2011071931
OPPOSITIONWO2011127255
OPPOSITIONWO2011140627
OPPOSITIONWO2012006369
OPPOSITIONWO2012006372
OPPOSITIONWO2012019168
OPPOSITIONWO2012030901
OPPOSITIONWO2012045075
OPPOSITIONWO2012045082
OPPOSITIONWO2012135805
OPPOSITIONWO2012158736
OPPOSITIONWO2012170930
OPPOSITIONWO2013039857
OPPOSITIONWO2013039861
OPPOSITIONWO2013052523
OPPOSITIONWO2013090648
OPPOSITIONWO2013130161
OPPOSITIONWO2013151664
OPPOSITIONWO2013151672
OPPOSITIONWO2013151736
OPPOSITIONWO2014081507
OPPOSITIONWO2018222926
SEARCHUS2009286852
SEARCHWO2009051451
SEARCHWO2011068810
SEARCHWO2012135805
SEARCHWO2013039857
SEARCHWO2013039861
SEARCHWO2013151736

Non-Patent Literature (NPL) Citations (83) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- R Scott Mcivor, "Therapeutic Delivery of mRNA: The Medium Is the Message", Molecular Therapy, (20110501), vol. 19, no. 5, doi:10.1038/mt.2011.67, ISSN 1525-0016, pages 822 - 823, XP055159404
OPPOSITION- Anonymous, "Lipofectamine® transfection reagents", White Paper Lipofectamine bulletin, (20120101), White Paper Lipofectamine bulletin, (20230103), XP093011416-
OPPOSITION- Anonymous, " N1-Methylpseudouridine", Wikipedia, (20220925), Wikipedia, URL: https://en.wikipedia.org/w/index.php?title=N1-Methylpseudouridine&oldid=1112313226, (20231128), XP093106654-
OPPOSITION- Brand Reindert C, Klootwijk Jacobus, Biochemischlaboratorium Rudi J Planta, Edward B, Maden H, " Biosynthesis of a Hypermodified Nucleotide in Saccharomyces carlsbergensis 17 S and HeLa-Cell 18 S Ribosomal Ribonucleic Acid", Biochem. J, (19780101), vol. 169, pages 71 - 77, XP055960175-
OPPOSITION- Buse, Et Al, "Properties, engineering and applications of lipid-based nanoparticle drug- delivery systems: current research and advances", Nanomedicine, (20100101), vol. 5, no. 8, XP093011509-
OPPOSITION- Campbell, N.A., Reece, J.B., Urry, L.A., Cain, M.L., Wasserman, S.A., Minorsky, P.V., Jackson, R.B., "Chapter 5: The Structure and Function of Large Biological Molecules", Campbell, N.A., Reece, J.B., Urry, L.A., Cain, M.L., Wasserman, S.A., Minorsky, P.V., Jackson, R.B., Campbell - Reece, Campbell Biology (8th ed.), US, Pearson/Cummings, (20080904), pages 68 - 91, ISBN 978-0-8053-6844-4, XP009550488-
OPPOSITION- CHARETTE M , GRAY M W, "Pseudouridine in RNA: What, where, how, and why", IUBMB Life, John Wiley & Sons, Inc., Hoboken, USA, Hoboken, USA, (20000101), vol. 49, no. 5, ISSN 1521-6543, pages 341 - 351, XP002598531-
OPPOSITION- C. S. YARIAN et al., "Structural and functional roles of the N1- and N3- protons of PSI at tRNA's position 39", Nucleic Acid Reasearch, (19990000), vol. 27, no. 17, pages 3543 - 3549, XP055959841-
OPPOSITION- De Barros Luís André, Branco, Tsourkas Andrew, Saboury Babak, Cardoso Valbert Nascimento, Alavi Abass, "Emerging role of radiolabeled nanoparticles as an effective diagnostic technique", EJNMMI Research, (20120101), vol. 2, no. 39, XP093011426-
OPPOSITION- Fang Jia-You, "Nano- or submicron-sized liposomes as carriers for drug delivery", Chang Gung medical journal. CGMJ = Chang Geng yixue zazhi, Chau-Xiong Zhang, CN, CN , (20060701), vol. 29, no. 4, ISSN 2072-0939, pages 358 - 362, XP093106659-
OPPOSITION- Immordino Maria Laura; Dosio Franco; Cattel Luigi, "Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential", INTERNATIONAL JOURNAL OF NANOMEDICINE, DOVE MEDICAL PRESS LTD., AUCKLAND, NZ, AUCKLAND, NZ , (20060101), vol. 1, no. 3, ISSN 1176-9114, pages 297 - 315, XP009145524-
OPPOSITION- Karikó Katalin; Weissman Drew, "Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, GB , (20070101), vol. 10, no. 5, ISSN 1367-6733, pages 523 - 532, XP009154595-
OPPOSITION- Karp Ian, Li Lina, Spalding Rebecca, "Intellia Presents Updated Interim Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis at the American Heart Association Scientific Sessions 2022", Intellia Therapeutics, (20221105), Intellia Therapeutics, URL: https://ir.intelliatx.com/node/10536/pdf, (20231128), XP093106671-
OPPOSITION- Kaur Tranum, Naser Tavakoli, Roderick Slavcev, Shawn Wettig, "Calorimetric Investigations of Non-Viral DNA Transfection Systems", Thermodynamics - Kinetics of Dynamic Systems, InTech, (20110922), pages 255 - 276, ISBN 978-953-30-7627-0, XP093107000-
OPPOSITION- KIM et al., "In vivo gene transfer to the mouse nasal cavity mucosa using a stable cationic lipid emulsion", Mol Cells., (20000430), vol. 10, no. 2, pages 142 - 147, XP019361343-
OPPOSITION- LIMBACH P A, CRAIN P F, MCCLOSKEY J A, "SUMMARY: THE MODIFIED NUCLEOSIDES OF RNA", Nucleic Acids Research, Oxford University Press, GB, GB , (19940625), vol. 22, no. 12, ISSN 0305-1048, pages 2183 - 2196, XP001152667-
OPPOSITION- Löbenberg R, Maas J, Kreuter J , "Improved Body Distribution of 14C-labelled AZT bound to Nanoparticles in Rats determined by Radioluminography", Journal of Drug Targeting, (19970101), vol. 5, no. 3, pages 171 - 179, XP093106913-
OPPOSITION- NAMY et al., "Translational Recoding and RNA Modifications", Topics in Current Genetics, (20050127), vol. 12, pages 309 - 340, XP093011673-
OPPOSITION- Pecot, Et Al., "RNA interference in the clinic: Challenges and future directions", Cancer, (20101216), vol. 11, no. 1, XP093011495-
OPPOSITION- P. F. AGRIS et al., "Thermodynamic contribution of nucleosides modifications to yeast tRNAPhe anticodon stem loop analogs", Acta Biochimica Polonica, (19990000), vol. 46, no. 1, pages 163 - 172, XP093011677-
OPPOSITION- P. M. RABINOVICH, "Synthetic Messenger RNA and Cell Metabolism Modulation", Methods in Molecular Biology, New York, (20130000), pages 1 - 323, XP093011679-
OPPOSITION- RANADE V V, "Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers", The Journal of clinical pharmacology, LIPPINCOTT CO, HAGERSTOWN, MD, US, US , (19890101), vol. 29, ISSN 0091-2700, pages 685 - 694, XP002982134-
OPPOSITION- URL: https://www.thermofisher.com/order/cata log/prod uct/L300000 1, XP093011758-
OPPOSITION- WEISSMAN ET AL., J IMMUNOL, (20000101), vol. 165, pages 4710 - 4717, XP002724713-
OPPOSITION- F. MARTINON, "Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome- entrapped mRNA", Eur. J. Immunol., (19930000), vol. 23, doi:10.1002/eji.1830230749, pages 1719 - 1722, XP002937540
OPPOSITION- MARTINON F., ET AL., "INDUCTION OF VIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES IN VIVO BY LIPOSOME-ENTRAPPED MRNA.", European Journal of Immunology, Wiley-VCH, Hoboken, USA, Hoboken, USA, (19930101), vol. 23., doi:10.1002/eji.1830230749, ISSN 0014-2980, pages 1719 - 1722., XP000618955
OPPOSITION- Minnaert An-Katrien, Dakwar George R., Benito Juan M., García Fernández José M., Ceelen W., De Smedt Stefaan C., Remaut Katrien, "High-Pressure Nebulization as Application Route for the Peritoneal Administration of siRNA Complexes", Macromolecular Bioscience, Wiley-VCH Verlag GmbH, DE, DE , (20171001), vol. 17, no. 10, doi:10.1002/mabi.201700024, ISSN 1616-5187, XP093011959
OPPOSITION- Motorin Yuri, Helm Mark, "RNA nucleotide methylation", Wiley Interdisciplinary Reviews: RNA, John Wiley & Sons Ltd, United Kingdom, United Kingdom , (20110901), vol. 2, no. 5, doi:10.1002/wrna.79, ISSN 1757-7004, pages 611 - 631, XP055959997
OPPOSITION- Weijun Li, Francis C. Szoka, "Lipid-based Nanoparticles for Nucleic Acid Delivery", Environmental Science and Pollution Research, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (20070301), vol. 24, no. 3, doi:10.1007/s11095-006-9180-5, ISSN 0724-8741, pages 438 - 449, XP055468868
OPPOSITION- Weijun Li ; Francis C. Szoka, "Lipid-based Nanoparticles for Nucleic Acid Delivery", Pharmaceutical Research, Kluwer Academic Publishers-Plenum Publishers, NL, NL , (20070125), vol. 24, no. 3, doi:10.1007/s11095-006-9180-5, ISSN 1573-904X, pages 438 - 449, XP019483494
OPPOSITION- M. THOMAS et al., "Non-viral siRNA delivery to the lung", Advanced Drug Delivery Reviews, (20070000), vol. 59, doi:10.1016/j.addr.2007.03.003, pages 124 - 133, XP022087319
OPPOSITION- OH et al., "siRNA delivery systems for cancer treatment", Adv Drug Deliv Rev., (20090810), vol. 61, no. 10, doi:10.1016/j.addr.2009.04.018, pages 850 - 862, XP026234415
OPPOSITION- Chang, Y.C. Herath, J. Wang, T.H.H. Chow, C.S., "Synthesis and solution conformation studies of 3-substituted uridine and pseudouridine derivatives", Bioorganic & Medicinal Chemistry, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20071119), vol. 16, no. 5, doi:10.1016/j.bmc.2007.11.039, ISSN 0968-0896, pages 2676 - 2686, XP022526163
OPPOSITION- Jonathan D. Finn, Amy Rhoden Smith, Mihir C. Patel, Lucinda Shaw, Madeleine R. Youniss, Jane Van Heteren, Tanner Dirstine, Corey Ciullo, Reynald Lescarbeau, Jessica Seitzer, Ruchi R. Shah, Aalok Shah, Dandan Ling, Jacqueline Growe, Melissa Pink, Ellen Rohde, Kristy M. Wood, William E. Salomon, William F. Harrington, Christian Dombrowski, Walter R. Strapps, Yong Chang, David V. Morrissey, "A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing", Cell Reports, Elsevier Inc, US, US , (20180201), vol. 22, no. 9, doi:10.1016/j.celrep.2018.02.014, ISSN 2211-1247, pages 2227 - 2235, XP055527484
OPPOSITION- A. YAMAMOTO et al., "Current prospects for mRNA gene delivery", European Journal of Pharmaceutics and Biopharmaceutics, (20090000), vol. 71, doi:10.1016/j.ejpb.2008.09.016, pages 484 - 489, XP025992169
OPPOSITION- Karikó K, Buckstein M, Ni H, Weissman D, "Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA", Immunity, Cell Press, AMSTERDAM, NL, AMSTERDAM, NL , (20050801), vol. 23, no. 2, doi:10.1016/J.IMMUNI.2005.06.008, ISSN 1074-7613, pages 165 - 175, XP002634064
OPPOSITION- KARIKO K., ET AL., "Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA", Immunity, Cell Press, AMSTERDAM, NL, AMSTERDAM, NL , (20050801), vol. 23, no. 2, doi:10.1016/J.IMMUNI.2005.06.008, ISSN 1074-7613, pages 165 - 175, XP008104240
OPPOSITION- Katalin Karikó, Michael Buckstein, Houping Ni, Drew Weissman, "Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA", Immunity, (20050000), vol. 23, pages 165 - 175, XP008104240
OPPOSITION- Geertrui Tavernier, Oliwia Andries, Jo Demeester, Niek N. Sanders, Stefaan C. De Smedt, Joanna Rejman, "mRNA as gene therapeutic: How to control protein expression", Journal of Controlled Release, Elsevier, (20110301), vol. 150, no. 3, doi:10.1016/j.jconrel.2010.10.020, ISSN 01683659, pages 238 - 247, XP055068617
OPPOSITION- Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu, Katalin Kariko, Barbara L. Mui, Ying K. Tam, Thomas D. Madden, Michael J. Hope, Drew Weissman, "Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20151101), vol. 217, doi:10.1016/j.jconrel.2015.08.007, ISSN 0168-3659, pages 345 - 351, XP055231069
OPPOSITION- Oliwia Andries, Séan Mc Cafferty, Stefaan C. De Smedt, Ron Weiss, Niek N. Sanders, Tasuku Kitada, "N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20151101), vol. 217, doi:10.1016/j.jconrel.2015.08.051, ISSN 0168-3659, pages 337 - 344, XP055231071
OPPOSITION- KARIKO K, ET AL., "PHOSPHATE-ENHANCED TRANSFECTION OF CATIONIC LIPID-COMPLEXED MRNA AND PLASMID DNA", BIOCHIMICA ET BIOPHYSICA ACTA., ELSEVIER, NL, NL , (19980101), vol. 1369, no. 02, doi:10.1016/S0005-2736(97)00238-1, ISSN 0006-3002, pages 320 - 334, XP001030876
OPPOSITION- M.Jayne Lawrence, Gareth D. Rees, "Microemulsion-based media as novel drug delivery systems", Advanced Drug Delivery Reviews, Elsevier, (20001201), vol. 45, no. 1, doi:10.1016/S0169-409X(00)00103-4, ISSN 0169409X, pages 89 - 121, XP055011623
OPPOSITION- Zimmermann, E. Muller, R.H., "Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN@?) dispersions in artificial gastrointestinal media", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20010901), vol. 52, no. 2, doi:10.1016/S0939-6411(01)00167-9, ISSN 0939-6411, pages 203 - 210, XP004301068
OPPOSITION- ZIMMERMANN et al., "Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media", Eur.J.Pharm.Biopharm., (20010000), vol. 52, doi:10.1016/S0939-6411(01)00167-9, page 203, XP004301068
OPPOSITION- ZIMMERMANN et al., "Electrolyte- and pH- stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media", Eur J Pharm Biopharm., vol. 52, no. 2, doi:10.1016/S0939-6411(01)00167-9, pages 203 - 210, XP004301068
OPPOSITION- Tenchov et al., "Lipid Nanoparticles - From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement", ACS Nano, (2021), vol. 15, doi:10.1021/acsnano.1c04996, XP093009618
OPPOSITION- Tenchov Rumiana, Bird Robert, Curtze Allison E., Zhou Qiongqiong, "Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement", ACS Nano, American Chemical Society, US, US , (20211123), vol. 15, no. 11, doi:10.1021/acsnano.1c04996, ISSN 1936-0851, pages 16982 - 17015, XP093009618
OPPOSITION- SU et al., "In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles", Mol Pharm., (20110606), vol. 8, no. 3, doi:10.1021/mp100390w, pages 774 - 787, XP055679420
OPPOSITION- X. SU et al., "In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles", Mol. Pharmaceutics, (20110321), vol. 8, doi:10.1021/mp100390w, pages 774 - 787, XP055679420
OPPOSITION- KARIKÓ et al., "Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability", Mol Ther., (20081101), vol. 19, no. 11, doi:10.1038/mt.2008.200, pages 1833 - 1840, XP055920956
OPPOSITION- KARIKÓ KATALIN ET AL, "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.", Molecular Therapy, Nature Publishing Group, GB, GB , (20081101), vol. 16, no. 11, doi:10.1038/mt.2008.200, ISSN 1525-0024, pages 1833 - 1840, XP002598556
OPPOSITION- K. KARIKÓ et al., "Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability", Molecular Therapy, (20080000), vol. 16, no. 11, doi:10.1038/mt.2008.200, pages 1833 - 1840, XP055920956
OPPOSITION- WHITEHEAD et al., "Synergistic silencing: Combinations of Lipid-like Materials for Efficacious siRNA Delivery", Mol. Ther ., (20110901), vol. 19, no. 9, doi:10.1038/mt.2011.141, pages 1688 - 1694, XP055067340
OPPOSITION- G. BASHA et al., "Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells", Mol. Ther., (20110000), vol. 19, doi:10.1038/mt.2011.190, pages 2186 - 2200, XP055024764
OPPOSITION- Genc Basha, Tatiana I Novobrantseva, Nicole Rosin, Yuen Yi C Tam, Ismail M Hafez, Matthew K Wong, Tsukasa Sugo, Vera M Ruda, June Qin, Boris Klebanov, Marco Ciufolini, Akin Akinc, Ying K Tam, Michael J Hope, Pieter R Cullis, "Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells", Molecular Therapy, No longer published by Elsevier, (20111201), vol. 19, no. 12, doi:10.1038/mt.2011.190, ISSN 15250016, pages 2186 - 2200, XP055024764
OPPOSITION- Katrijn Broos, Kevin Van Der Jeught, Janik Puttemans, Cleo Goyvaerts, Carlo Heirman, Heleen Dewitte, Rein Verbeke, Ine Lentacker, Kris Thielemans, Karine Breckpot, "Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon", Molecular Therapy-Nucleic Acids, Cell Press, US, US , (20160101), vol. 5, doi:10.1038/mtna.2016.38, ISSN 2162-2531, page e326, XP055482633
OPPOSITION- Sork Helena, Nordin Joel Z, Turunen Janne J, Wiklander Oscar Pb, Bestas Burcu, Zaghloul Eman M, Margus Helerin, Padari Kärt, Duru Adil D, Corso Giulia, Bost Jeremy, Vader Pieter, Pooga Margus, Smith Ci Edvard, Wood Matthew Ja, Schiffelers Raymond M, Hällbrink Mattias, Andaloussi Samir El, "Lipid-based Transfection Reagents Exhibit Cryo-induced Increase in Transfection Efficiency", Molecular Therapy-Nucleic Acids, Cell Press, US, US , (20160308), vol. 5, doi:10.1038/mtna.2016.8, ISSN 2162-2531, XP093011958
OPPOSITION- Sean C Semple; Akin Akinc; Jianxin Chen; Ammen P Sandhu; Barbara L Mui; Connie K Cho; Dinah W Y Sah; Derrick Stebbing; Erin J Crosley; Ed Yaworski; ET AL, "Rational design of cationic lipids for siRNA delivery", Nature Biotechnology, (20100000), vol. 28, no. 2, pages 172 - 178, XP002633693
OPPOSITION- Sean C Semple, Akin Akinc, Jianxin Chen, Ammen P Sandhu, Barbara L Mui, Connie K Cho, Dinah W Y Sah, Derrick Stebbing, Erin J Crosley, Ed Yaworski, et al., "Rational design of cationic lipids for siRNA delivery", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20100201), vol. 28, no. 2, doi:10.1038/NBT.1602, ISSN 1087-0156, pages 172 - 176, XP002633693
OPPOSITION- M. KORMANN et al., "Expression or therapeutic proteins after delivery or chemically modified mRNA in mice", nature biotechnology, (20110000), vol. 29, no. 2, doi:10.1038/nbt.1733, pages 154 - 159, XP055040839
OPPOSITION- Ugur Sahin, Katalin Karikó, Özlem Türeci, "mRNA-based therapeutics — developing a new class of drugs", Nature Reviews Drug Discovery, Nature Pub. Group, vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 14741776, pages 759 - 780, XP055159205
OPPOSITION- Newby Meredith I., Greenbaum Nancy L., "Sculpting of the spliceosomal branch site recognition motif by a conserved pseudouridine", NATURE STRUCTURAL BIOLOGY., Nature Publishing Group., NEW YORK, NY, US, NEW YORK, NY, US , (20021201), vol. 9, no. 12, doi:10.1038/nsb873, ISSN 1072-8368, pages 958 - 965, XP055804022
OPPOSITION- Rohner Eduarde, Yang Ran, Foo Kylie S., Goedel Alexander, Chien Kenneth R., "Unlocking the promise of mRNA therapeutics", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20221101), vol. 40, no. 11, doi:10.1038/s41587-022-01491-z, ISSN 1087-0156, pages 1586 - 1600, XP093106668
OPPOSITION- Gillmore Julian D., Gane Ed, Taubel Jorg, Kao Justin, Fontana Marianna, Maitland Michael L., Seitzer Jessica, O’connell Daniel, Walsh Kathryn R., Wood Kristy, Phillips Jonathan, Xu Yuanxin, Amaral Adam, Boyd Adam P., Cehelsky Jeffrey E., Mckee Mark D., Schiermeier Andrew, Harari Olivier, Murphy Andrew, Kyratsous Christos A., Zambrowicz Brian, Soltys Randy, Gutstein David E., Leonard John, Sepp-Lorenzino Laura, Lebwohl David, "CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis", The New England journal of medicine, Massachusetts Medical Society, US, US , (20210805), vol. 385, no. 6, doi:10.1056/NEJMoa2107454, ISSN 0028-4793, pages 493 - 502, XP055978811
OPPOSITION- Andrew J. Geall, Ayush Verma, Gillis R. Otten, Christine A. Shaw, Armin Hekele, Kaustuv Banerjee, Yen Cu, Clayton W. Beard, Luis A. Brito, Thomas Krucker, Derek T. O�Hagan, Manmohan Singh, Peter W. Mason, Nicholas M. Valiante, Philip R. Dormitzer, Susan W. Barnett, Rino Rappuoli, Jeffrey B. Ulmer, Christian W. Mandl, "Nonviral delivery of self-amplifying RNA vaccines.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20120904), vol. 109, no. 36, doi:10.1073/PNAS.1209367109, ISSN 0027-8424, pages 14604 - 14609, XP002683929
OPPOSITION- MALONE R. W., FELGNER P. L., VERMA I. M., "CATIONIC LIPOSOME-MEDIATED RNA TRANSFECTION.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (19890801), vol. 86., no. 16., doi:10.1073/pnas.86.16.6077, ISSN 0027-8424, pages 6077 - 6081., XP000604642
OPPOSITION- Rouf Nusrat Zahan, Biswas Sumit, Tarannum Nawseen, Oishee Labiba Mustabina, Muna Mutia Masuka, "Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases", RNA BIOLOGY, (20221231), vol. 19, no. 1, doi:10.1080/15476286.2022.2055923, ISSN 1547-6286, pages 386 - 410, XP093106666
OPPOSITION- Rosenberg S. A., Zhai Y., Yang J. C., Schwartzentruber D. J., Hwu P., Marincola F. M., Topalian S. L., Restifo N. P., Seipp C. A., Einhorn J. H., White D. E., Roberts B., "Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens", Journal of the National Cancer Institute, Oxford University Press, GB, GB , (19981216), vol. 90, no. 24, doi:10.1093/jnci/90.24.1894, ISSN 0027-8874, pages 1870 - 1872, XP093011479
OPPOSITION- Yuri Motorin, Et Al., "5-methylcytosine in RNA: detection, enzymatic formation and biological functions", Nucleic Acids Research, Oxford University Press, GB, GB , (20100301), vol. 38, no. 5, doi:10.1093/nar/gkp1117, ISSN 0305-1048, pages 1415 - 1430, XP055681117
OPPOSITION- B. ANDERSON et al., "Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation", Nucleic Acids Research, (20100000), vol. 38, no. 17, doi:10.1093/nar/gkq347, pages 5884 - 5892, XP055041208
OPPOSITION- B. R. Anderson, H. Muramatsu, S. R. Nallagatla, P. C. Bevilacqua, L. H. Sansing, D. Weissman, K. Kariko, "Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation", Nucleic Acids Research, Information Retrieval Ltd., (20100901), vol. 38, no. 17, doi:10.1093/nar/gkq347, ISSN 03051048, pages 5884 - 5892, XP055041208
OPPOSITION- B. R. Anderson, H. Muramatsu, B. K. Jha, R. H. Silverman, D. Weissman, K. Kariko, "Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L", Nucleic Acids Research, Information Retrieval Ltd., (20111101), vol. 39, no. 21, doi:10.1093/nar/gkr586, ISSN 03051048, pages 9329 - 9338, XP055126203
OPPOSITION- Beck Jan D., Reidenbach Daniel, Salomon Nadja, Sahin Ugur, Türeci Özlem, Vormehr Mathias, Kranz Lena M., "mRNA therapeutics in cancer immunotherapy", Molecular Cancer, (20211201), vol. 20, no. 1, doi:10.1186/s12943-021-01348-0, XP093034772
OPPOSITION- James C. Kaczmarek, Kowalski Piotr S., Anderson Daniel G., "Advances in the delivery of RNA therapeutics: from concept to clinical reality", Genome Medicine, (20171201), vol. 9, no. 1, doi:10.1186/s13073-017-0450-0, XP055464283
OPPOSITION- PASCOLO, "Vaccination With Messenger RNA", DNA Vaccines: Methods and Protocols, (20060822), vol. Chapter, pages 23 - 40, XP009117840
OPPOSITION- Virovic Lucija, Wu Catherine H, Konishi Masayoshi, Wu George Y, "Novel delivery methods for treatment of viral hepatitis: an update", Expert Opinion on Drug Delivery, Informa Healthcare, GB, GB , (20050701), vol. 2, no. 4, doi:10.1517/17425247.2.4.707, ISSN 1742-5247, pages 707 - 717, XP093106636
OPPOSITION- Chen Gang, Zhang Xiao, Yang Fan, Mu Lei, "Disposition of Nanoparticle-Based Delivery System via Inner Ear Administration", CURRENT DRUG METABOLISM, BENTHAM SCIENCE PUBLISHERS,, US, US , (20101201), vol. 11, no. 10, doi:10.2174/138920010794479673, ISSN 1389-2002, pages 886 - 897, XP093106634
OPPOSITION- Souto Eliana B., Doktorovova Slavomira, Gonzalez-Mira Elisabet, Egea Maria Antonia, Garcia Maria Luisa, "Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs", Current eye research, Informa Healthcare USA, US, US , (20100701), vol. 35, no. 7, doi:10.3109/02713681003760168, ISSN 0271-3683, pages 537 - 552, XP093106901
OPPOSITION- SCHLAKE T, THESS A, FOTIN-MLECZEK M, KALLEN K-J, "Developing mRNA-vaccine technologies", RNA BIOLOGY, (20121101), vol. 9, no. 11, doi:10.4161/rna.22269, ISSN 1547-6286, pages 1319 - 1330, XP002743467
OPPOSITION- T. SCHLAKE et al., "Developing mRNA-vaccine technologies", RNA Biology, vol. 9, no. 11, doi:10.4161/rna.22269, (20121012), pages 1319 - 1330, XP055561756
SEARCH[ ] - NORBERT PARDI ET AL, "Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes", JOURNAL OF CONTROLLED RELEASE., NL, (201511), vol. 217, doi:10.1016/j.jconrel.2015.08.007, ISSN 0168-3659, pages 345 - 351, XP055231069 [ ] * abstract *
SEARCH[ ] - OLIWIA ANDRIES ET AL, "N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice", JOURNAL OF CONTROLLED RELEASE., NL, (201511), vol. 217, doi:10.1016/j.jconrel.2015.08.051, ISSN 0168-3659, pages 337 - 344, XP055231071 [ ] * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents